Cochrane Abstracts
Temozolomide for high grade glioma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Temozolomide for High Grade Glioma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma.
Temozolomide for high grade glioma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma. Accessed January 31, 2025.
Temozolomide for high grade glioma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma
Temozolomide for High Grade Glioma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Temozolomide for high grade glioma
ID - 435511
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
